# Emerging Therapeutic Approaches for Tic Alleviation in Tourette Syndrome: The Role of Micronutrients

**Authors:** Samskruthi Madireddy, Sahithi Madireddy

PMC · DOI: 10.3390/neurolint18010007 · 2025-12-26

## TL;DR

This paper reviews how micronutrients like vitamins and minerals may help reduce tics in Tourette syndrome by affecting brain chemistry and function.

## Contribution

The paper provides a novel synthesis of how specific micronutrient deficiencies may influence tic disorders and their potential as therapeutic tools.

## Key findings

- Micronutrients such as vitamin D, B6, and iron may modulate tic symptoms through effects on neurotransmitter systems.
- Deficiencies in zinc, magnesium, and copper are linked to altered neurodevelopment and immune activity in tic disorders.
- Nutrient-based interventions could serve as adjunctive strategies in managing tic disorder severity.

## Abstract

Tourette syndrome (TS), or Tourette’s, is a tic disorder (TD) belonging to a group of neuropsychiatric conditions marked by recurrent motor movements or vocalizations known as tics. TD, including TS, typically begins in childhood between 4 and 18 years of age and affects approximately 3% of children and adolescents. The etiology and pathogenesis of TD are multifactorial, involving genetic, immunologic, psychological, and environmental factors. Evidence suggests that neurotransmitter dysregulation, particularly within the cortical dopaminergic networks of the basal ganglia and limbic system, which support motor control and cognition, may be involved in the development of TD. Nutritional factors may modulate TD through various mechanisms, including effects on neurotransmitter synthesis and metabolism, neurodevelopment, neural architecture, and neuroimmune activity. This review integrates current evidence on the roles of vitamins D, B6, and A, as well as iron, magnesium, zinc, and copper, in TD. For each micronutrient, its physiological and neurobiological functions are discussed, along with possible mechanistic links to TD pathophysiology. Additionally, we summarize the impact of nutrient deficiencies and assess available evidence regarding their potential therapeutic potential role in TD management. Overall, this synthesis highlights how nutritional status may influence TD onset and symptom severity, suggesting that nutrient-based interventions could potentially serve as valuable adjunctive strategies in treatment.

## Linked entities

- **Chemicals:** vitamin B6 (PubChem CID 1054), vitamin A (PubChem CID 445354), iron (PubChem CID 23925), magnesium (PubChem CID 5462224), zinc (PubChem CID 23994), copper (PubChem CID 23978)
- **Diseases:** Tourette syndrome (MONDO:0007661), tic disorder (MONDO:0002420)

## Full-text entities

- **Diseases:** tics (MESH:D020323), nutrient deficiencies (MESH:D007153), TD (MESH:D013981), TS (MESH:D005879), neuropsychiatric conditions (MESH:D001523)
- **Chemicals:** copper (MESH:D003300), vitamins D, B6, and A (-), zinc (MESH:D015032), iron (MESH:D007501), magnesium (MESH:D008274)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12845030/full.md

---
Source: https://tomesphere.com/paper/PMC12845030